Skip to main content
. 2018 Jun 26;18:691. doi: 10.1186/s12885-018-4449-8

Table 3.

Association of α-internexin protein expression with clinicopathological variables

Characteristics N Reduced/loss of expression (%) χ2 value P value
GEP-NENs (n = 286)
Functional status 6.213 0.013
 Nonfunctional 234 179(76.5)
 Functional 52 31(59.6)
Tumor location 2.356 0.308
 Gastrointestinal tract 162 124(76.5) 2.340d 0.126d
  Rectum 60 32(53.3) 43.470e < 0.001e
  Stomach 43 42(97.7)
  Duodenum 21 17(81.0)
  Esophagus 18 18(100)
  Jejunum/ileum 9 9(100)
  Appendix 6 2(33.3)
  Colon 5 4(80.0)
 Pancreas 93 63(67.7)
 Other 31 23(74.2)
Tumor gradea 49.934 < 0.001
 G1 120 69(57.5)
 G2 57 36(63.2)
 G3 101 99(98.0)
Tumor typea 46.807 < 0.001
 NET 180 108(60.0)
 NEC + MANEC 98 96(98.0)
Tumor stage 28.106 < 0.001
 I + II 140 83(59.3)
 III + IV 146 127(87.0)
GI-NENs (n = 162)
Tumor gradeb 41.938 < 0.001
 G1 60 31(51.7)
 G2 21 14(66.7)
 G3 75 74(98.7)
Tumor typeb 40.004 < 0.001
 NET 81 45(55.6)
 NEC + MANEC 75 74(98.7)
Tumor stage 25.786 < 0.001
 I + II 74 43(58.1)
 III + IV 88 81(92.0)
pNENs (n = 93)
Tumor gradec 2.929 0.231
 G1 54 34(63.0)
 G2 27 19(70.4)
 G3 10 9(90.0)
Tumor typec 1.080 0.299
 NET 84 56(66.7)
 NEC + MANEC 7 6(85.7)
Tumor stage 4.638 0.031
 I + II 60 36(60.0)
 III + IV 33 27(81.8)

a 278 cases both for tumor grade and tumor type; b 156 cases both for tumor grade and tumor type; c 91cases both for tumor grade and tumor type; d The χ2 and P value were computed by the contrast between gastrointestinal tract and pancreas; e The χ2 and P value were computed by the contrast among different sites of gastrointestinal tract

GEP-NEN: Gastroenteropancreatic neuroendocrine neoplasm; NET: Neuroendocrine tumor; NEC: Neuroendocrine carcinoma; MANEC: Mixed adenoneuroendocrine carcinoma; GI-NEN: Gastrointestinal neuroendocrine neoplasm; pNEN: Pancreatic neuroendocrine neoplasm